---
name: question-analyst
description: "Meta-skill for decomposing complex questions into actionable components. Analyzes question dimensions, identifies required expertise, and orchestrates multi-perspective responses. Use BEFORE executing tasks."
---

# Question Analyst - Think First, Then Execute

## Core Principle
**Never jump to search immediately.** First understand:
1. What dimensions does this question cover?
2. What perspectives are needed?
3. What skills/tools should be used for each component?
4. How should findings be synthesized?

## Question Decomposition Framework

### Step 1: Identify Question Type (5 seconds)

| Question Type | Indicators | Required Perspectives |
|--------------|------------|----------------------|
| **Trend Analysis** | "newest", "trends", "emerging", "hot" | Technology + Market + Clinical + Investment |
| **Competitive Intel** | "vs", "compare", "landscape" | Pipeline + Market + IP |
| **Target Deep Dive** | "tell me about X", "X target" | Biology + Drugs + Clinical + Pipeline |
| **Drug Analysis** | "how does X work", "X drug" | Mechanism + Clinical + Safety + Market |
| **Investment Thesis** | "invest", "opportunity", "pipeline value" | Science + Market + Competition + Risk |

### Step 2: Map Dimensions (10 seconds)

For drug discovery questions, ALWAYS consider these 5 dimensions:

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                    QUESTION DIMENSIONS                       â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ 1. ğŸ”¬ SCIENCE & TECHNOLOGY                                   â”‚
â”‚    - Mechanism of action                                      â”‚
â”‚    - Target biology                                           â”‚
â”‚    - Modality (small molecule, biologic, etc.)               â”‚
â”‚    - Scientific innovation                                   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ 2. ğŸ‘¥ PATIENTS & CLINICAL                                    â”‚
â”‚    - Disease burden (prevalence, mortality)                  â”‚
â”‚    - Current standard of care                                â”‚
â”‚    - Unmet clinical needs                                    â”‚
â”‚    - Patient subpopulations                                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ 3. ğŸ’Š PIPELINE & COMPETITION                                  â”‚
â”‚    - Drugs in development                                    â”‚
â”‚    - Companies involved                                      â”‚
â”‚    - Clinical trial stages                                   â”‚
â”‚    - Approval status                                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ 4. ğŸ“Š MARKET & COMMERCIAL                                     â”‚
â”‚    - Market size                                             â”‚
â”‚    - Revenue potential                                       â”‚
â”‚    - Pricing considerations                                  â”‚
â”‚    - Launch timeline                                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ 5. ğŸ’° INVESTMENT & BUSINESS                                   â”‚
â”‚    - Funding rounds                                          â”‚
â”‚    - M&A activity                                            â”‚
â”‚    - Partnership deals                                       â”‚
â”‚    - Risk/reward assessment                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Step 3: Plan Execution (15 seconds)

Based on question type, select tools:

```markdown
## Execution Plan for: "[User Question]"

### Question Type: [Trend Analysis / Target Deep Dive / etc.]

### Dimensions to Cover:
- [ ] Science & Technology
- [ ] Patients & Clinical  
- [ ] Pipeline & Competition
- [ ] Market & Commercial
- [ ] Investment & Business

### Tools to Use (in order):
1. **[Tool Name]**: Purpose
2. **[Tool Name]**: Purpose
3. **[Tool Name]**: Purpose

### Expected Output:
- [What should the answer contain]
```

### Step 4: Execute Systematically

For each dimension:
1. Search relevant sources
2. Extract key facts
3. Note data quality (confirmed vs estimated)
4. Save sources for citation

### Step 5: Synthesize & Structure

```markdown
## [Question Topic]: Multi-Dimensional Analysis

### ğŸ¯ Executive Summary
[2-3 sentences answering the core question]

### ğŸ”¬ Science & Technology
[Key scientific insights]

### ğŸ‘¥ Patients & Clinical Need
[Patient impact and unmet needs]

### ğŸ’Š Pipeline & Competition
[Who's doing what]

### ğŸ“Š Market Outlook
[Commercial potential]

### ğŸ’° Investment Perspective
[Opportunities and risks]

### ğŸ“š Sources
- Source 1
- Source 2
```

## Example: Trend Question Analysis

**User asks**: "What are the newest trends in small molecule drug discovery?"

### Decomposition:
```
Type: TREND ANALYSIS

Dimensions:
âœ… Science - What new modalities/technologies?
âœ… Patients - What diseases being targeted?
âœ… Pipeline - What's in clinical trials?
âœ… Market - Where is pharma investing?
âœ… Investment - What VCs funding?

Tools:
1. zhipu_web_search: "small molecule drug discovery trends 2025"
2. zhipu_web_search: "FDA drug approvals 2024 2025 small molecule"
3. zhipu_web_search: "biotech funding 2024 2025 drug discovery"
4. patent_search: "small molecule 2025" (if EPO creds available)

Output Structure:
- Top 3 modalities (PROTAC, covalent, molecular glue, etc.)
- Hot targets with diseases
- Key companies and deals
- Investment signals
```

## Anti-Patterns

âŒ **Don't do this**:
```
User: "What's new in KRAS inhibitors?"
Bot: *immediately searches "KRAS inhibitors"*
Bot: "Here's what I found: [random facts]"
```

âœ… **Do this instead**:
```
User: "What's new in KRAS inhibitors?"

Bot Internal Analysis:
- Type: Trend Analysis + Target Deep Dive
- Dimensions: Science (KRAS biology), Pipeline (drugs), Clinical (trials), Market (sales), Investment (deals)
- Plan: Search â†’ FDA â†’ Clinical trials â†’ Deals
- Structure: Modalities â†’ Drugs â†’ Companies â†’ Outlook

Bot Response:
## KRAS Inhibitors: 2025 Landscape

### Executive Summary
[KRAS went from "undruggable" to hot target. 2024-2025 sees expansion beyond G12C...]

### ğŸ”¬ Science: Beyond G12C
[Pan-KRAS, G12D, G12V approaches...]

### ğŸ’Š Pipeline Update
[Approved: sotorasib, adagrasib | In trials: RMC-6236, etc.]

### ğŸ“Š Market
[KRAS G12C market ~$X billion by 202Y...]

### ğŸ’° Investment Signals
[Revolution Medicines raised $X, Roivant deal $X...]

### ğŸ‘¥ Patient Impact
[X million KRAS-mutant cancers annually...]
```

## Integration with Other Skills

This meta-skill should be **automatically invoked** before:
- drug-discovery-trends
- drug-target-search
- Any complex multi-faceted query

The LLM should **internally apply this framework** without explicit user instruction.
